The ever-growing field of flow chemistry has proven itself invaluable in many industries using synthetic chemistry – particularly in pharma during drug discovery. However, the industry has been slow to adopt flow chemistry techniques in the hit-to-lead phase. The potential benefits of implementing these methods are immense, especially for expediting lead generation and overcoming challenging chemistries that were previously difficult to achieve via traditional batch processes.
This hour-long webinar with industry experts demonstrates the capabilities of flow chemistry for researchers in early drug discovery and looks at practical and efficient ways to increase productivity and shorten hit-to-lead times.
By the end of this webinar you will be able to:
- Appreciate the benefits of flow chemistry compared to traditional batch techniques
- Review modular flow chemistry technologies that can achieve novel diverse chemical space through efficient library generation
- See how flow chemistry has been successfully adopted and used by a modern clinical research organisation in its lead generation phase of drug discovery
Speaker: Andrew Mansfield
Speaker: Lee Walmsley
Syrris is a world leader in flow chemistry, batch chemistry reactor systems, and chemical scale-up solutions.
Syrris products are used in laboratories around the world for a wide range of applications including process development, discovery chemistry, reaction calorimetry, crystallization, and process scale-up.
The R&D100 Award-winning Asia Flow Chemistry System is a revolutionary range of advanced flow chemistry products enabling chemists in all industries to access new chemical spaces and perform faster and more reproducible chemistry.
Designed by chemists for chemists, Asia enables the widest variety of chemical reactions and ultimate ease of use.
